Skip to main content

Theophylline 24-Hour Extended Release Capsules and Tablets Shortage

Last Updated: April 13, 2025
Status: Current

Products Affected - Description
    • Theophylline extended release tablet, Glenmark, 400 mg, bottle, 100 count, NDC 68462-0380-01
    • Theophylline extended release tablet, Glenmark, 600 mg, bottle, 100 count, NDC 68462-0356-01
    • Theophylline extended release tablet, Rhodes, 400 mg, bottle, 100 count, NDC 42858-0701-01
    • Theophylline extended release tablet, Rhodes, 600 mg, bottle, 100 count, NDC 42858-0702-01 - discontinued
Reason for the Shortage
    • Endo has Theo-24 extended-release capsules available.
    • Rhodes did not provide a reason for the shortage of theophylline 400 mg extended-release tablets. Rhodes discontinued the 600 mg extended-release tablets in May 2024 due to a business decision.
    • Glenmark did not provide a reason for the shortage.
Available Products
    • Theo-24 extended release capsule, Endo Pharmaceuticals, 100 mg, bottle, 100 count, NDC 52244-0100-10
    • Theo-24 extended release capsule, Endo Pharmaceuticals, 200 mg, bottle, 100 count, NDC 52244-0200-10
    • Theo-24 extended release capsule, Endo Pharmaceuticals, 300 mg, bottle, 100 count, NDC 52244-0300-10
    • Theo-24 extended release capsule, Endo Pharmaceuticals, 400 mg, bottle, 100 count, NDC 52244-0400-10

Estimated Resupply Dates

    • Glenmark has theophylline 400 mg and 600 mg tablets on back order and the company estimates a release date of late-April 2025.
    • Rhodes has theophylline 400 mg extended-release tablets on back order and the company cannot estimate a release date.

Updated

Updated April 13, 2025 by Elyse MacDonald, PharmD, MS, BCPS. Created August 22, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer